Skip to main content
Premium Trial:

Request an Annual Quote

Genosity, Igentify Collaborate on Genetic Counseling Software, Ink Comarketing Deal

NEW YORK – Genosity and Igentify announced Tuesday a strategic collaboration to integrate Genosity's Integrated Genomic Toolkit into Igentify's genetic counseling software.

Under the terms of the agreement, both firms will comarket the combined solution. Financial and other terms of the deal were not disclosed.

"Our integrated system not only provides a solution for the operational aspects of all genetic testing, from patient enrollment to result report, but also enables our clients to build their data-driven knowledge base that can help them advance research, improve patient care, and engage in commercial collaborations," Genosity CEO and Cofounder Marc Grodman said in a statement. The system will be able to interface with electronic medical records systems, the firms noted.

Israel-based Igentify is the latest partnership for genomics software and lab services provider Iselin, New Jersey-based Genosity, which also has comarketing agreements with ArcherDx and Personal Genome Diagnostics, a strategic collaboration with Olink Proteomics, and a research partnership with Columbia University to study wild-type cardiac amyloidosis, a rare heart disorder.

"Igentify is proud to combine our efforts with Genosity to allow the first of its kind comprehensive software solution that enables healthcare providers to establish genomic core centers of excellence comprising patient counselling, bioinformatics and a laboratory information management system for better patient care," Igentify CEO and Cofounder Doron Behar said in a statement. "Demand for genetic testing is rising quickly, but a shortage of genetic counselors makes it impossible to scale up personal genetic counselling services, leaving health care providers unable to fulfill patient needs."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more